デフォルト表紙
市場調査レポート
商品コード
1670929

シングルセルオミックスの世界市場レポート 2025年

Single-Cell Omics Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
シングルセルオミックスの世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

シングルセルオミックスの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR17.0%で45億2,000万米ドルに成長します。予測期間の成長は、臨床への導入と診断、マルチオミクスアプローチとの統合、再生医療への応用、医薬品開発と発見、細胞療法と免疫療法に起因します。予測期間の主な動向としては、in vivoシングルセル調査、感染症調査におけるシングルセルオミックス、マイクロ流体工学とシングルセルソーティング、シングルセルマルチオミクス統合、空間シングルセルプロファイリングなどが挙げられます。

がん罹患率の増加は、シングルセルオミックス市場の今後の成長を促進すると予想されています。がんは、異常な細胞が制御不能に増殖し、正常な境界を破って他の臓器に広がったり、近隣の組織に侵入したりすることで、体内のほぼすべての臓器や組織に発生する可能性のあるさまざまな疾患を包含します。がんの診断、予後予測、特定の臨床集団における新しい治療標的の発見のためのバイオマーカーの同定は、シングルセルオミックスデータに大きく依存しています。例えば、2024年5月、米国政府機関である国立衛生研究所(National Institutes of Health)は、2022年1月現在、米国では約1,810万人ががんサバイバーとして生活していると報告しました。この数字は2032年までに2,250万人に増加すると予測されています。このように、がんの有病率の上昇がシングルセルオミックス市場の成長を後押ししています。

臨床試験の増加も、シングルセルオミックス市場の成長を促進すると予測されています。臨床試験は、医療介入、治療、薬剤の安全性と有効性を評価するためにヒトを対象として実施される必須の調査研究であり、大幅な急増が見られます。臨床試験にシングルセルオミックスを応用することで、個々の細胞の詳細な分析が容易になり、細胞の不均一性に関する貴重な知見が得られ、精密医療へのアプローチが強化されます。2023年5月17日現在、Xtalksの報告によると、ClinicalTrials.govに登録された臨床試験は世界全体で452,604件あり、2021年初頭に報告された365,000件以上から大幅に増加しています。このような臨床試験の急増は、シングルセルオミックス市場の成長促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のシングルセルオミックス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界のシングルセルオミックス市場:成長率分析
  • 世界のシングルセルオミックス市場の実績:規模と成長, 2019-2024
  • 世界のシングルセルオミックス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界のシングルセルオミックス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のシングルセルオミックス市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単一細胞ゲノミクス
  • 単一細胞トランスクリプトミクス
  • 単一細胞プロテオミクス
  • 単一細胞メタボロミクス
  • 世界のシングルセルオミックス市場:技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細胞分離技術
  • サンプル調製技術
  • 次世代シーケンシングの分析
  • 世界のシングルセルオミックス市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腫瘍
  • 細胞生物
  • 神経
  • 免疫
  • 世界のシングルセルオミックス市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬およびバイオテクノロジー企業
  • 学術研究機関
  • 病院および診断検査室
  • その他のエンドユーザー
  • 世界のシングルセルオミックス市場、単一細胞ゲノミクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 全ゲノム配列解析(WGS)
  • ターゲットシーケンシング
  • 単一細胞DNA分析キット
  • 世界のシングルセルオミックス市場、単一細胞トランスクリプトミクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • RNAシーケンシング(RNA-seq)
  • 単一細胞のための定量PCR(qPCR)
  • 単一細胞遺伝子発現解析キット
  • 世界のシングルセルオミックス市場、単一細胞プロテオミクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 質量分析に基づくプロテオミクス
  • 抗体ベースのタンパク質分析
  • 単一細胞タンパク質分析キット
  • 世界のシングルセルオミックス市場、単一細胞メタボロミクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 代謝物の質量分析
  • 核磁気共鳴(NMR)メタボロミクス
  • 単一細胞代謝物プロファイリングキット

第7章 地域別・国別分析

  • 世界のシングルセルオミックス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のシングルセルオミックス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • シングルセルオミックス市場:競合情勢
  • シングルセルオミックス市場:企業プロファイル
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fischer Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Agilent Technologies Inc.
  • Sartorius AG
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V
  • DiaSorin S.p.A.
  • Tecan Group Ltd.
  • BGI Genomics Co. Ltd.
  • Promega Corporation
  • 10x Genomics Inc.
  • Takara Bio Inc.
  • NanoString Technologies Inc.
  • Vizgen
  • HiFiBiO Therapeutics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • シングルセルオミックス市場2029:新たな機会を提供する国
  • シングルセルオミックス市場2029:新たな機会を提供するセグメント
  • シングルセルオミックス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r25300

Single-cell omics refers to the analysis and profiling of individual cells obtained from diverse populations, enabling the examination and understanding of both healthy and diseased cellular processes at a granular, single-cell level. This approach is instrumental in studying cellular heterogeneity, identifying cell types, conducting disease research, and developing therapeutic interventions.

The primary types of single-cell omics products encompass single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Single-cell genomics, for instance, is an advanced technique used to classify individual cells, identifying unique cell types and characterizing distinct cellular features. Various technologies are employed in single-cell omics, including cell isolation and sample preparation methods, as well as next-generation sequencing analysis. These technologies find application across diverse fields such as oncology, cell biology, neurology, immunology, and others. End users of single-cell omics products include pharmaceutical and biotechnology companies, academic and research institutions, hospital and diagnostic laboratories, and other relevant entities involved in advancing scientific research and medical applications.

The single-cell omics market research report is one of a series of new reports from The Business Research Company that provides single-cell omics market statistics, including single-cell omics industry global market size, regional shares, competitors with a single-cell omics market share, detailed single-cell omics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell omics industry. This single-cell omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell omics market size has grown rapidly in recent years. It will grow from $2.08 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to cellular heterogeneity discovery, the emergence of single-cell analysis tools, biomedical research progress, immune system characterization, and the rise of precision medicine

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to clinical adoption and diagnostics, integration with multi-omics approaches, application in regenerative medicine, drug development and discovery, cellular therapies and immunotherapies. Major trends in the forecast period include in vivo single-cell studies, single-cell omics in infectious disease research, microfluidics and single-cell sorting, single-cell multi-omics integration, and spatial single-cell profiling.

The increasing incidence of cancer is anticipated to drive the growth of the single-cell omics market in the future. Cancer encompasses a range of diseases that can arise in almost any organ or tissue in the body when abnormal cells grow uncontrollably, breach their normal boundaries, and either spread to other organs or invade nearby tissues. The identification of biomarkers for cancer diagnosis, prognosis prediction, and the discovery of new therapeutic targets in specific clinical cohorts has heavily relied on single-cell omics data. For example, in May 2024, the National Institutes of Health, a U.S. government agency, reported that as of January 2022, around 18.1 million individuals in the United States were living as cancer survivors. This figure is projected to increase to 22.5 million by 2032. Thus, the rising prevalence of cancer is propelling the growth of the single-cell omics market.

The increasing number of clinical trials is also expected to propel the growth of the single-cell omics market. Clinical trials, essential research studies conducted on human subjects to evaluate the safety and efficacy of medical interventions, treatments, or drugs, have seen a substantial surge. The application of single-cell omics in clinical trials facilitates detailed analyses of individual cells, offering valuable insights into cellular heterogeneity and enhancing precision medicine approaches. As of May 17, 2023, Xtalks reported that there are 452,604 registered clinical trials globally on ClinicalTrials.gov, representing a significant increase from the over 365,000 registered trials reported in early 2021. This surge in clinical trials serves as a driving factor for the growth of the single-cell omics market.

Product innovation stands out as a pivotal trend gaining traction in the single-cell omics market, with major companies actively pursuing the development of cutting-edge products to maintain their market positions. A notable example is Deepcell, a US-based software provider specializing in single-cell dimensional morphology analysis, which, in May 2023, introduced the REM-I Platform. This platform represents a scalable solution for single-cell imaging, high-dimensional analysis, and cell sorting, providing unprecedented insights into cell biology. The REM-I Platform is poised to catalyze new discoveries across various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening. Its unique combination of single-cell imaging, sorting, and high-dimensional analysis is expected to open new avenues for exploration and research.

Major companies in the single-cell omics market are concentrating on the development of advanced kits tailored for single-cell applications to drive market revenues. Sequencing kits, pre-packaged sets of reagents and materials designed for genetic sequencing processes, play a crucial role in streamlining laboratory workflows. Singular Genomics Systems, Inc., a US-based company specializing in novel next-generation sequencing, exemplifies this trend. In February 2023, the company launched the Max Read Kits for single-cell sequencing on the G4 Sequencing Platform. These kits, compatible with popular 10x Genomics assays, offer flexibility for sequencing 4 to 16 samples per run. The Max Read Kits deliver 800 million reads per flow cell with 80% to 90% Q30 quality. Singular Genomics has also elevated the quality specifications of the G4 Sequencing Platform's F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for select applications. This strategic focus on advanced sequencing kits aligns with the industry's commitment to enhancing efficiency and precision in single-cell omics applications.

In March 2022, Singleron Biotechnologies, a genomics company based in China, successfully acquired Proteona Pte. Ltd for an undisclosed sum. This strategic acquisition was driven by Singleron's objective to extend its global footprint and gain access to Proteona's cutting-edge technologies specialized in single-cell multi-omic analysis. Proteona, headquartered in Singapore, is a precision medicine firm recognized for its proficiency in single-cell proteogenomic analysis.

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single-cell omics market includes revenues earned by entities through single-cell sorting and isolation, single-cell sample preparation kits, and related single-cell data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Omics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell omics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell omics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-cell omics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Proteomics; Single-Cell Metabolomics
  • 2) By Technology: Cell Isolation Technologies; Sample Preparation Technologies; Analysis Of Next-Generation Sequencing
  • 3) By Application: Oncology; Cell Biology; Neurology; Immunology
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Organizations; Hospital And Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Single-Cell Genomics: Whole Genome Sequencing (WGS); Targeted Sequencing; Single-Cell DNA Analysis Kits
  • 2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq); Quantitative PCR (qPCR) For Single Cells; Single-Cell Gene Expression Analysis Kits
  • 3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics; Antibody-Based Protein Analysis; Single-Cell Protein Analysis Kits
  • 4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites; Nuclear Magnetic Resonance (NMR) Metabolomics; Single-Cell Metabolite Profiling Kits
  • Companies Mentioned: Danaher Corporation; Merck KGaA; Becton Dickinson and Company; GE HealthCare Technologies Inc.; Thermo Fischer Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single-Cell Omics Market Characteristics

3. Single-Cell Omics Market Trends And Strategies

4. Single-Cell Omics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Single-Cell Omics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Single-Cell Omics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Single-Cell Omics Market Growth Rate Analysis
  • 5.4. Global Single-Cell Omics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Single-Cell Omics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Single-Cell Omics Total Addressable Market (TAM)

6. Single-Cell Omics Market Segmentation

  • 6.1. Global Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
  • Single-Cell Proteomics
  • Single-Cell Metabolomics
  • 6.2. Global Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Isolation Technologies
  • Sample Preparation Technologies
  • Analysis Of Next-Generation Sequencing
  • 6.3. Global Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cell Biology
  • Neurology
  • Immunology
  • 6.4. Global Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Organizations
  • Hospital And Diagnostic Laboratories
  • Other End Users
  • 6.5. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Sequencing (WGS)
  • Targeted Sequencing
  • Single-Cell DNA Analysis Kits
  • 6.6. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNA Sequencing (RNA-seq)
  • Quantitative PCR (qPCR) For Single Cells
  • Single-Cell Gene Expression Analysis Kits
  • 6.7. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry-Based Proteomics
  • Antibody-Based Protein Analysis
  • Single-Cell Protein Analysis Kits
  • 6.8. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry For Metabolites
  • Nuclear Magnetic Resonance (NMR) Metabolomics
  • Single-Cell Metabolite Profiling Kits

7. Single-Cell Omics Market Regional And Country Analysis

  • 7.1. Global Single-Cell Omics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Single-Cell Omics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Single-Cell Omics Market

  • 8.1. Asia-Pacific Single-Cell Omics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Single-Cell Omics Market

  • 9.1. China Single-Cell Omics Market Overview
  • 9.2. China Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Single-Cell Omics Market

  • 10.1. India Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Single-Cell Omics Market

  • 11.1. Japan Single-Cell Omics Market Overview
  • 11.2. Japan Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Single-Cell Omics Market

  • 12.1. Australia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Single-Cell Omics Market

  • 13.1. Indonesia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Single-Cell Omics Market

  • 14.1. South Korea Single-Cell Omics Market Overview
  • 14.2. South Korea Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Single-Cell Omics Market

  • 15.1. Western Europe Single-Cell Omics Market Overview
  • 15.2. Western Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Single-Cell Omics Market

  • 16.1. UK Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Single-Cell Omics Market

  • 17.1. Germany Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Single-Cell Omics Market

  • 18.1. France Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Single-Cell Omics Market

  • 19.1. Italy Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Single-Cell Omics Market

  • 20.1. Spain Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Single-Cell Omics Market

  • 21.1. Eastern Europe Single-Cell Omics Market Overview
  • 21.2. Eastern Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Single-Cell Omics Market

  • 22.1. Russia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Single-Cell Omics Market

  • 23.1. North America Single-Cell Omics Market Overview
  • 23.2. North America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Single-Cell Omics Market

  • 24.1. USA Single-Cell Omics Market Overview
  • 24.2. USA Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Single-Cell Omics Market

  • 25.1. Canada Single-Cell Omics Market Overview
  • 25.2. Canada Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Single-Cell Omics Market

  • 26.1. South America Single-Cell Omics Market Overview
  • 26.2. South America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Single-Cell Omics Market

  • 27.1. Brazil Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Single-Cell Omics Market

  • 28.1. Middle East Single-Cell Omics Market Overview
  • 28.2. Middle East Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Single-Cell Omics Market

  • 29.1. Africa Single-Cell Omics Market Overview
  • 29.2. Africa Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Single-Cell Omics Market Competitive Landscape And Company Profiles

  • 30.1. Single-Cell Omics Market Competitive Landscape
  • 30.2. Single-Cell Omics Market Company Profiles
    • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Thermo Fischer Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Single-Cell Omics Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Illumina Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Qiagen N.V
  • 31.7. DiaSorin S.p.A.
  • 31.8. Tecan Group Ltd.
  • 31.9. BGI Genomics Co. Ltd.
  • 31.10. Promega Corporation
  • 31.11. 10x Genomics Inc.
  • 31.12. Takara Bio Inc.
  • 31.13. NanoString Technologies Inc.
  • 31.14. Vizgen
  • 31.15. HiFiBiO Therapeutics

32. Global Single-Cell Omics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single-Cell Omics Market

34. Recent Developments In The Single-Cell Omics Market

35. Single-Cell Omics Market High Potential Countries, Segments and Strategies

  • 35.1 Single-Cell Omics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Single-Cell Omics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Single-Cell Omics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer